NFE2L2 and Alzheimer disease: This latter effect may potentially involve NFE2L2 and KEAP1's role in mitochondrial motility [29], since depletion of NFE2L2 inhibits mitochondrial motility [29] and NFE2L2 induction elicits neuroprotection in AD models [97–99, 115].